Archimed
GP Profile: ArchiMed
Following the close of its new €1bn fund, ArchiMed's Denis Ribon discusses the firm's fundraising experience and investment pipeline
ArchiMed closes MED Platform I on €1bn
Oversubscribed fund closes above its €800m target after a couple of years on the road
ArchiMed's Bomi bolts on Logifarma
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy
Warburg Pincus invests in ArchiMed-backed Polyplus
ArchiMed and Warburg will be equal shareholders, while the management of Polyplus will retain a minority
How private equity is helping fight the Covid-19 outbreak
A round-up of initiatives by GPs across Europe – and their portfolio companies – to help their communities
NorthEdge sells DHG to ArchiMed for 3x return
During NorthEdge's holding period, the company made bolt-ons such as Nightingale, Kirton and Qbitus
ArchiMed appoints three new partners
Berthoux and Desmottes join as operating partners, while Philips becomes a strategic partner
Aksìa buys dental group Primo from Archimed
Sale ends a four-year holding period for French GP Archimed, which owned a 48% stake in the firm
ArchiMed-backed Micromed bolts on OSG
MicroMed has now made three acquisitions in the neurology diagnostics market with this acquisition
ArchiMed acquires Eurolyser and Eurolab
Transaction is part of a succession agreement that will see a co-founder of Eurolyser retire
French GPs opt for organic diversification
Recent fund closes show that organic diversification is still a valid option for some GPs and VCs willing to step out of their comfort zones
Sector specialisation taking hold in Europe
European private equity firms are sharpening their investment focus by restricting the number of sectors they target
